PLASMA-LEVEL OF TUMOR-NECROSIS-FACTOR IN DISSEMINATED INTRAVASCULAR COAGULATION

被引:56
作者
WADA, H
OHIWA, M
KANEKO, T
TAMAKI, S
TANIGAWA, M
TAKAGI, M
MORI, Y
SHIRAKAWA, S
机构
[1] Second Department of Internal Medicine, Mie University School of Medicine, Tsu City, Mie Ken
关键词
TNF; ORGAN FAILURE; DIC;
D O I
10.1002/ajh.2830370302
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The plasma level of tumor necrosis factor (TNF) was determined in 20 normal individuals, 52 patients with disseminated intravascular coagulation (DIC), 22 pre-DIC patients, and 39 non-DIC patients. TNF was not detected in the normal subjects, and the level was very low in non-DIC patients. However, the TNF level was significantly elevated in DIC patients, and it was moderately increased in pro-DIC patients shortly before the onset of DIC. This increase in circulating TNF may be associated with DIC. TNF was higher in DIC associated with solid cancer than in DIC associated with leukemia or sepsis. The increase in plasma TNF level was widely correlated with DIC score, and it was significantly increased in patients with poor prognosis. However, the plasma TNF level in DIC patients with organ failure was not significantly different from those without organ failure. We conclude that the increase in circulating TNF reflects the pathogenic factors in DIC rather than being a consequence of organ failure due to DIC.
引用
收藏
页码:147 / 151
页数:5
相关论文
共 50 条
  • [21] TUMOR-NECROSIS-FACTOR-ALPHA AND SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTORS IN INDIVIDUALS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    ZANGERLE, R
    GALLATI, H
    SARCLETTI, M
    WACHTER, H
    FUCHS, D
    IMMUNOLOGY LETTERS, 1994, 41 (2-3) : 229 - 234
  • [22] Increased plasma-soluble fibrin monomer levels in patients with disseminated intravascular coagulation
    Wada, H
    Wakita, Y
    Nakase, T
    Shimura, M
    Hiyoyama, K
    Nagaya, S
    Deguchi, H
    Mori, Y
    Kaneko, T
    Deguchi, K
    Fujii, J
    Shiku, H
    AMERICAN JOURNAL OF HEMATOLOGY, 1996, 51 (04) : 255 - 260
  • [23] Increased plasma soluble adhesion molecules in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation
    Shimura, M
    Wada, H
    Hiyoyama, K
    Nakasaki, T
    Takagi, M
    Deguchi, A
    Mori, Y
    Nisikawa, M
    Deguchi, K
    Shiku, H
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 1998, 4 (03) : 196 - 200
  • [24] PLASMA THROMBOMODULIN AS A MARKER OF VASCULAR DISORDERS IN THROMBOTIC THROMBOCYTOPENIC PURPURA AND DISSEMINATED INTRAVASCULAR COAGULATION
    WADA, H
    OHIWA, M
    KANEKO, T
    TAMAKI, S
    TANIGAWA, M
    SHIRAKAWA, S
    KOYAMA, M
    HAYASHI, T
    SUZUKI, K
    AMERICAN JOURNAL OF HEMATOLOGY, 1992, 39 (01) : 20 - 24
  • [25] Elevated plasma levels of fibrin degradation products by granulocyte-derived elastase in patients with disseminated intravascular coagulation
    Matsumoto, T
    Wada, H
    Nobori, T
    Nakatani, K
    Onishi, K
    Nishikawa, M
    Shiku, H
    Kazahaya, Y
    Sawai, T
    Koike, K
    Matsuda, M
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2005, 11 (04) : 391 - 400
  • [26] THE ROLE OF TUMOR-NECROSIS-FACTOR IN THE REGULATION OF ANTIGEN PRESENTATION BY HUMAN MONOCYTES
    ZEMBALA, M
    KOWALCZYK, D
    PRYJMA, J
    RUGGIERO, I
    MYTAR, B
    KLYSIK, J
    STEC, WJ
    INTERNATIONAL IMMUNOLOGY, 1990, 2 (04) : 337 - 342
  • [27] DETECTION OF TUMOR-NECROSIS-FACTOR ACTIVITY IN THE SUPERNATANTS OF FELINE MACROPHAGES AND LYMPHOCYTES
    LIN, DS
    BOWMAN, DD
    COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 1993, 16 (01) : 91 - 94
  • [28] TUMOR-NECROSIS-FACTOR AS AN ADJUNCT TO FRACTIONATED RADIOTHERAPY IN THE TREATMENT OF MURINE TUMORS
    NISHIGUCHI, I
    WILLINGHAM, V
    MILAS, L
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1990, 18 (03): : 555 - 558
  • [29] VASCULAR CHANGES AND DEMYELINATION INDUCED BY THE INTRANEURAL INJECTION OF TUMOR-NECROSIS-FACTOR
    REDFORD, EJ
    HALL, SM
    SMITH, KJ
    BRAIN, 1995, 118 : 869 - 878
  • [30] ROLE OF TUMOR-NECROSIS-FACTOR IN THE TUMOR-NECROTIZING ACTIVITY OF AGENTS WITH DIVERGING TOXICITY
    VANDEWIEL, PA
    VANDERPIJL, A
    BLOKSMA, N
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1991, 33 (02) : 115 - 120